However, the aforementioned results indicated a significantly greater level of efficiency and efficacy when utilising an All-in-one plasmid to induce targeted DNA methylation alterations in the EBF3 target region across a panel of human melanoma cell lines. This evidence concerns the gene EBF3 and melanoma.